Showing results (21-30 of 166) with videos related to

Sort By:
Pageof 17
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Exploring associations between psychotic experiences and structural brain age: a population-based study in late adolescenceConstantinos Constantinides, Doretta Caramaschi, Stanley Zammit, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 29, 2020
Acute and chronic effects of Δ9-tetrahydrocannabinol (THC) on cerebral blood flow: A systematic reviewM Olabisi Ogunbiyi, Chandni Hindocha, Tom P Freeman, et al.
Social Cognitive and Affective Neuroscience|February 15, 2014
Dopamine, urges to smoke, and the relative salience of drug versus non-drug rewardTom P Freeman, Ravi K Das, Sunjeev K Kamboj, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2010
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]Celia J A Morgan, Gráinne Schafer, Tom P Freeman, et al.
The Lancet Regional Health. Europe|November 22, 2021
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment ratesJakob Manthey, Tom P Freeman, Carolin Kilian, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2010
Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabisCelia J A Morgan, Tom P Freeman, Gráinne L Schafer, et al.
Addiction (Abingdon, England)|July 15, 2021
Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependenceJack Wilson, Katherine Mills, Tom P Freeman, et al.
The Lancet. Psychiatry|July 28, 2022
Association of cannabis potency with mental ill health and addiction: a systematic reviewKat Petrilli, Shelan Ofori, Lindsey Hines, et al.
Elife|November 13, 2019
The effects of psychosocial stress on dopaminergic function and the acute stress responseMichael Ap Bloomfield, Robert A McCutcheon, Matthew Kempton, et al.
The International Journal on Drug Policy|February 12, 2022
Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey in nightlife attendeesMeryem Grabski, Jon Waldron, Tom P Freeman, et al.
Pageof 17